IRMC has developed protocols to streamline and expedite the care of stroke patients, which includes evaluation and initiation of treatment with a clot-busting drug called tPA within three hours of first symptoms – for patients deemed appropriate. This medication, which has been used for many years as a treatment for heart attack, has now been found to save lives and decrease disability for certain types of stroke. Patients for whom the drug is appropriate must begin treatment within three hours after first symptoms. IRMC has been awarded the Gold Seal of Approval™ and designation as a Primary Stroke Center of Excellence by the Joint Commission, which examined the above protocol.

IRMC’s neuro-interventionalist team provides advanced treatment for ischemic strokes using a procedure known as mechanical thrombectomy, a technique that has revolutionized stroke care in the United States. An ischemic stroke is caused by a blood clot that blocks the flow of blood to portions of the brain, and nearly 87% of strokes are ischemic.

While not an option for all patients, mechanical thrombectomy – which can be used to treat even the most severe cases – uses a catheter to reach the blockage and then entangles the clot in a wire mesh stent for removal. Each patient’s recovery is individualized, but research clearly shows the procedure has positive results for one of every three patients if treated within 24 hours. This dramatically increases a patient’s chances of returning to his or her pre-stroke health following the procedure.

Our interventional neurology team recently helped a patient recover from a stroke and return to work at the Sheriff’s Office. To hear his story, click here.

The addition of our highly trained neuro-inverventionalists moves IRMC toward the goal of becoming a Comprehensive Stroke Center. For additional information, call our Interventional Neurology and Stroke Clinic at (772) 448-8600.